This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Sunday, May 19, 2013
DDW 2013- HCV patients with late viral breakthrough have similar characteristics
HCV patients with late viral breakthrough have similar characteristics
May 19, 2013
ORLANDO, Fla. — Viral breakthrough during the interferon/ribavirin phase of hepatitis C triple therapy was associated with genotype 1a and advanced liver fibrosis, similar to findings in previous clinical trials, according to study data presented here at Digestive Disease Week.
“We’ve noticed that there are patients who were experiencing viral breakthrough later in treatment,” Kali Zhou, MD, a resident in the department of medicine at the University of California, Los Angeles, told Infectious Disease News. “We did see later viral breakthrough in clinical trials, but we haven’t evaluated whether the characteristics of our breakthrough patients were similar to those who broke through in clinical trials.”...
Continue reading @ Healio
HCV prevalence higher among Asian-Americans
May 19, 2013
ORLANDO, Fla. — There was a higher prevalence of hepatitis C infection among Asian-Americans than among non-Asians who received care at a free community clinic, researchers reported at Digestive Disease Week.
“Among non-Asians, the prevalence of HCV was similar to what was seen in NHANES data,” Mindie Nguyen, MD, associate professor of medicine at Stanford University, told Infectious Disease News. “Worldwide, a large amount of the HCV burden is in Asia, and we lacked data on whether Asian-Americans have a higher HCV prevalence that is similar to that in their countries of origin. We found that the prevalence of HCV among Asian-Americans was similar to the reported prevalence in many parts of Asia and Southeast Asia.”
Continue reading@ Healio
Additional headlines from Digestive Disease Week 2013 Meeting @ Healio
No difference in IVF success rates in IPAA vs non-IPAA patients
May 19, 2013
Meeting News Coverage
Long-term study data indicates sustained improvement in GERD
May 19, 2013
Meeting News Coverage
HCV prevalence higher among Asian-Americans
May 19, 2013
Meeting News Coverage
H. pylori infection less common among patients with Barrett's esophagus, erosive esophagitis
May 19, 2013
Meeting News Coverage
HCV patients with late viral breakthrough have similar characteristics
May 19, 2013
Meeting News Coverage
Patients with Medicaid less likely to receive HCV treatment
May 18, 2013
Meeting News Coverage
Coffee consumption linked to reduced risk for primary sclerosing cholangitis
May 18, 2013
Meeting News Coverage
HBV may increase risk for non-Hodgkin lymphoma
May 18, 2013
Meeting News Coverage
Patterns of exhaled volatile organic compounds differ between obese, healthy children
May 18, 2013
No comments:
Post a Comment